Evidence map›Paper›PMID 26285014›Full record

ArticlePloS one2015

Impact of AMP-Activated Protein Kinase α1 Deficiency on Tissue Injury following Unilateral Ureteral Obstruction.

Sobuj Mia, Giuseppina Federico, Martina Feger, Tatsiana Pakladok, Adrian Meissner, Jakob Voelkl, Hermann-Josef Groene, Ioana Alesutan, Florian Lang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Reprogramming of Energy Metabolism in HumanInternational journal of molecular sciences · 2024
    Article
  3. MRTF: Basic Biology and Role in Kidney Disease.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Is TAK1 a Direct Upstream Kinase of AMPK?International journal of molecular sciences · 2018
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sobuj MiaDepartment of Physiology, University of Tübingen, Gmelinstr. 5, D-72076, Tübingen, Germany.
Giuseppina FedericoDepartment of Cellular and Molecular Pathology, German Cancer Research Center, Im Neuenheimer Feld, 280, 69120, Heidelberg, Germany.
Martina FegerDepartment of Physiology, University of Tübingen, Gmelinstr. 5, D-72076, Tübingen, Germany.
Tatsiana PakladokDepartment of Physiology, University of Tübingen, Gmelinstr. 5, D-72076, Tübingen, Germany.
Adrian MeissnerDepartment of Physiology, University of Tübingen, Gmelinstr. 5, D-72076, Tübingen, Germany.
Jakob VoelklDepartment of Physiology, University of Tübingen, Gmelinstr. 5, D-72076, Tübingen, Germany.
Hermann-Josef GroeneDepartment of Cellular and Molecular Pathology, German Cancer Research Center, Im Neuenheimer Feld, 280, 69120, Heidelberg, Germany.
Ioana AlesutanDepartment of Physiology, University of Tübingen, Gmelinstr. 5, D-72076, Tübingen, Germany.
Florian LangDepartment of Physiology, University of Tübingen, Gmelinstr. 5, D-72076, Tübingen, Germany.
University of Tübingen · DEGerman Cancer Research Center · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAMP-activated protein kinase (Ampk) is a sensor of the cellular energy status and a powerful regulator of metabolism. Activation of Ampk was previously shown to participate in monocyte-to-fibroblast transition and matrix protein production in renal tissue. Thus, the present study explored whether the catalytic Ampkα1 isoform participates in the regulation of the renal fibrotic response following unilateral ureteral obstruction (UUO).

methodsUUO was induced in gene-targeted mice lacking functional Ampkα1 (Ampkα1-/-) and in corresponding wild-type mice (Ampkα1+/+). In the obstructed kidney and, for comparison, in the non-obstructed control kidney, quantitative RT-PCR, Western blotting and immunostaining were employed to determine transcript levels and protein abundance, respectively.

resultsIn Ampkα1+/+ mice, UUO significantly up-regulated the protein abundance of the Ampkα1 isoform, but significantly down-regulated the Ampkα2 isoform in renal tissue. Phosphorylated Ampkα protein levels were significantly increased in obstructed kidney tissue of Ampkα1+/+ mice but not of Ampkα1-/- mice. Renal expression of α-smooth muscle actin was increased following UUO, an effect again less pronounced in Ampkα1-/- mice than in Ampkα1+/+ mice. Histological analysis did not reveal a profound effect of Ampkα1 deficiency on collagen 1 protein deposition. UUO significantly increased phosphorylated and total Tgf-ß-activated kinase 1 (Tak1) protein, as well as transcript levels of Tak1-downstream targets c-Fos, Il6, Pai1 and Snai1 in Ampkα1+/+ mice, effects again significantly ameliorated in Ampkα1-/- mice. Moreover, Ampkα1 deficiency inhibited the UUO-induced mRNA expression of Cd206, a marker of M2 macrophages and of Cxcl16, a pro-fibrotic chemokine associated with myeloid fibroblast formation. The effects of Ampkα1 deficiency during UUO were, however, paralleled by increased tubular injury and apoptosis.

conclusionsRenal obstruction induces an isoform shift from Ampkα2 towards Ampkα1, which contributes to the signaling involved in cell survival and fibrosis.

Indexed as

AMP-Activated Protein KinasesAnimalsBlotting, WesternCells, CulturedFibrosisImmunoenzyme TechniquesKidney DiseasesMiceMice, KnockoutMyofibroblastsReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerUreteral ObstructionAMP-Activated Protein KinasesPrkaa1 protein, mouseRNA, Messenger

Identifiers

PMID26285014
PMCPMC4540418
OpenAlexW1789099357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.